![Frontiers | Interferon α Enhances B Cell Activation Associated With FOXM1 Induction: Potential Novel Therapeutic Strategy for Targeting the Plasmablasts of Systemic Lupus Erythematosus Frontiers | Interferon α Enhances B Cell Activation Associated With FOXM1 Induction: Potential Novel Therapeutic Strategy for Targeting the Plasmablasts of Systemic Lupus Erythematosus](https://www.frontiersin.org/files/MyHome%20Article%20Library/498703/498703_Thumb_400.jpg)
Frontiers | Interferon α Enhances B Cell Activation Associated With FOXM1 Induction: Potential Novel Therapeutic Strategy for Targeting the Plasmablasts of Systemic Lupus Erythematosus
![IJMS | Free Full-Text | Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy IJMS | Free Full-Text | Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy](https://pub.mdpi-res.com/ijms/ijms-23-02366/article_deploy/html/images/ijms-23-02366-g001.png?1645438877)
IJMS | Free Full-Text | Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy
![Cells | Free Full-Text | Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies Cells | Free Full-Text | Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies](https://pub.mdpi-res.com/cells/cells-10-03017/article_deploy/html/images/cells-10-03017-g001.png?1636361951)
Cells | Free Full-Text | Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies
![Dynamic control of type I IFN signalling by an integrated network of negative regulators: Trends in Immunology Dynamic control of type I IFN signalling by an integrated network of negative regulators: Trends in Immunology](https://www.cell.com/cms/attachment/2026479355/2045374570/gr1.jpg)
Dynamic control of type I IFN signalling by an integrated network of negative regulators: Trends in Immunology
![Frontiers | Type I Interferons in Systemic Autoimmune Diseases: Distinguishing Between Afferent and Efferent Functions for Precision Medicine and Individualized Treatment Frontiers | Type I Interferons in Systemic Autoimmune Diseases: Distinguishing Between Afferent and Efferent Functions for Precision Medicine and Individualized Treatment](https://www.frontiersin.org/files/Articles/633821/fphar-12-633821-HTML/image_m/fphar-12-633821-g003.jpg)
Frontiers | Type I Interferons in Systemic Autoimmune Diseases: Distinguishing Between Afferent and Efferent Functions for Precision Medicine and Individualized Treatment
![Frontiers | Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications Frontiers | Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications](https://www.frontiersin.org/files/MyHome%20Article%20Library/790122/790122_Thumb_400.jpg)
Frontiers | Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications
![Cells | Free Full-Text | Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus Cells | Free Full-Text | Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus](https://pub.mdpi-res.com/cells/cells-08-00963/article_deploy/html/images/cells-08-00963-g001.png?1569567949)
Cells | Free Full-Text | Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus
![IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axis: Trends in Endocrinology & Metabolism IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axis: Trends in Endocrinology & Metabolism](https://www.cell.com/cms/attachment/fa0014b8-677b-4fcf-9a22-2d08c826182d/gr1_lrg.jpg)
IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axis: Trends in Endocrinology & Metabolism
![Cells | Free Full-Text | Cartilage and Bone Destruction in Arthritis: Pathogenesis and Treatment Strategy: A Literature Review Cells | Free Full-Text | Cartilage and Bone Destruction in Arthritis: Pathogenesis and Treatment Strategy: A Literature Review](https://www.mdpi.com/cells/cells-08-00818/article_deploy/html/images/cells-08-00818-g001.png)
Cells | Free Full-Text | Cartilage and Bone Destruction in Arthritis: Pathogenesis and Treatment Strategy: A Literature Review
![Cells | Free Full-Text | Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases Cells | Free Full-Text | Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases](https://pub.mdpi-res.com/cells/cells-09-01627/article_deploy/html/images/cells-09-01627-g001.png?1602239391)
Cells | Free Full-Text | Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases
![Effect of topical interferon-γ gene therapy using gemini nanoparticles on pathophysiological markers of cutaneous scleroderma in Tsk/+ mice | Gene Therapy Effect of topical interferon-γ gene therapy using gemini nanoparticles on pathophysiological markers of cutaneous scleroderma in Tsk/+ mice | Gene Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fgt.2011.159/MediaObjects/41434_2012_Article_BFgt2011159_Fig1_HTML.jpg)
Effect of topical interferon-γ gene therapy using gemini nanoparticles on pathophysiological markers of cutaneous scleroderma in Tsk/+ mice | Gene Therapy
![IJMS | Free Full-Text | Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils IJMS | Free Full-Text | Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils](https://pub.mdpi-res.com/ijms/ijms-22-04726/article_deploy/html/images/ijms-22-04726-g001.png?1619746864)